ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
ACCENDRA HEALTH INC/VA/
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.22−0.01 (-6.30%)
Close on Oct 19, 2026
- Market cap
- $16.89M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$4.5798 (−95.41%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
ACCENDRA HEALTH INC/VA/ saw revenue fall 3.3% to $2.65B over the twelve months to Jun 30, 2026. Free cash flow was -$357.19M.
Revenue
$2.65B
-3.3% vs. a year earlier
Operating income
$29.35M
TTM Q2 2026
Free cash flow
-$357.19M
TTM Q2 2026
EPS, diluted
-$3.92
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $16.89M
- P/E ratio
- –
- Price to sales
- 0.01
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -2115.02%
Fundamentals
- Revenue
- $2.65B
- Net income
- -$302.14M
- EPS, diluted
- -$3.92
- Free cash flow
- -$357.19M
- Book value per share
- -$7.18
- Diluted shares
- 77M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$2.65B-3.3% YoY
Gross profit
$1.19B-40.4% YoY
Operating income
$29.35M
Net income
-$302.14M
EPS, diluted
-$3.92
Free cash flow
-$357.19M
Reported periodTrailing twelve months